The European Commission is due to publish its long-awaited pharmaceutical package on March 29, which is set to include proposals for revisions of the EU’s pharmaceutical legislation and specific legislation on medicines for children and rare diseases, as well as a Council Recommendation on combating antimicrobial resistance.
This Dods EU Political Intelligence report provides a one-stop guide to the forthcoming pharmaceutical package, including a preview of the expected Commission measures and next steps, and a selection of views from political groups and stakeholders, including links to original sources.